0001104659-18-038713.txt : 20180606
0001104659-18-038713.hdr.sgml : 20180606
20180606213326
ACCESSION NUMBER: 0001104659-18-038713
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180312
FILED AS OF DATE: 20180606
DATE AS OF CHANGE: 20180606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MICEK JOHN
CENTRAL INDEX KEY: 0001243187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36714
FILM NUMBER: 18885061
MAIL ADDRESS:
STREET 1: 300 HAMILTON AVENUE, 4TH FLOOR
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jaguar Health, Inc.
CENTRAL INDEX KEY: 0001585608
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 MISSION STREET, SUITE 2375
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-896-5081
MAIL ADDRESS:
STREET 1: 201 MISSION STREET, SUITE 2375
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: Jaguar Animal Health, Inc.
DATE OF NAME CHANGE: 20130830
4
1
a4.xml
4
X0306
4
2018-03-12
0
0001585608
Jaguar Health, Inc.
JAGX
0001243187
MICEK JOHN
C/O JAGUAR HEALTH, INC.
201 MISSION STREET, SUITE 2375
SAN FRANCISCO
CA
94105
1
0
0
0
Stock Option (right to buy)
8.40
2018-03-12
4
A
0
38643
0
A
2027-08-02
Common Stock
38643
38643
D
Stock Option (right to buy)
2.39
2018-06-01
4
A
0
146804
0
A
2028-05-14
Common Stock
146804
146804
D
Granted pursuant to the Issuer's 2014 Equity Incentive Plan
All share numbers and the exercise price reflect the 1-for-15 reverse stock split effected on June 1, 2018.
The option grant was approved by the Issuer's board of directors on August 2, 2017, subject to shareholder approval of the amendment to the 2014 Stock Incentive Plan. The Issuer's shareholders approved the amendment on March 12, 2018.
Vests in equal monthly installments, beginning August 2, 2017, such that it is vested in full on the 3-year anniversary of the grant date.
The option grant was approved by the Issuer's board of directors on May 14, 2018, subject to the stockholders approving and effecting a reverse stock split. The Issuer's shareholders approved the reverse stock split on May 18, 2018 and effected such stock split on June 1, 2018.
Vests in equal monthly installments, beginning on May 14, 2018, such that it is vested in full on the 3-year anniversary of the grant date.
/s/ Karen S. Wright, Attorney-in-Fact
2018-06-06